A Phase 1b, Single-centre, Open-label Study to Evaluate Food Effect and the Drug-Drug Interaction of Omeprazole, Itraconazole and Rifampin on Tinlarebant in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Geographic AtrophyEye - Diseases / disorders of the eye
- Registration Number
- ACTRN12624000031561
- Lead Sponsor
- RBP4 Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 49
Inclusion Criteria
Healthy male or female, aged between 18 to 65 years of age, inclusive, at screening.
Exclusion Criteria
History of any clinically significant disorder, including cardiovascular (including unstable angina, myocardial infarction, chronic heart failure), haematologic, pulmonary, hepatic, renal, gastrointestinal, connective tissue disease, uncontrolled endocrine/metabolic, oncologic (within the last 5 years), neurologic (including seizures, strokes, brain tumours), and psychiatric diseases, or any disorder that the PI (or delegate) considers may prevent the successful completion of the study or influence the absorption, distribution, metabolism, excretion, or action of the study drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method